Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 7, 2019
Amelioration of the nigrostriatal pathway facilitated by ultrasound-mediated neurotrophic delivery in early Parkinson's diseaseMaria Eleni Karakatsani, Shutao Wang, Gesthimani Samiotaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2007
Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's diseaseCeline Perier, Jordi Bové, Du-Chu Wu, et al.
Nature Neuroscience|June 9, 2009
Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's diseaseYanping Li, Wencheng Liu, Tinmarla F Oo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 10, 2015
α-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal Parkinsonism protein Atp13a2Lauren R Kett, Barbara Stiller, Megan M Bernath, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 5, 2003
Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's diseasePatrice D Smith, Stephen J Crocker, Vernice Jackson-Lewis, et al.
Free Radical Biology & Medicine|July 21, 2009
Neuronal NOS and cyclooxygenase-2 contribute to DNA damage in a mouse model of Parkinson diseaseTuan Hoang, Dong-Kug Choi, Makiko Nagai, et al.
Journal of Neurochemistry|September 2, 2005
CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonismRobert M Silva, Vincent Ries, Tinmarla Frances Oo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 24, 2003
Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's diseaseStephen J Crocker, Patrice D Smith, Vernice Jackson-Lewis, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 12, 2002
Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTPWilliam Dauer, Nikolai Kholodilov, Miquel Vila, et al.
Neurotoxicity Research|December 4, 2009
Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's diseaseWei Zhang, Kester Phillips, Albert R Wielgus, et al.
Pageof 5